Applicability of the Global Lung Function Initiative-2022 spirometry reference equations among healthy adults in Iraq

全球肺功能倡议-2022肺活量测定参考方程在伊拉克健康成年人中的适用性

阅读:2

Abstract

The Global Lung Function Initiative (GLI) has developed race-neutral reference equations to represent global diversity better and improve fairness across populations. However, the applicability of these equations across different populations, including Middle Eastern populations, remains to be explored. This study aimed to evaluate the suitability of the GLI-2022 equations among healthy Iraqi adults. A cross-sectional study was conducted on 3,828 healthy non-smoking adults (49.8% females) who were 18 years and older. Spirometric measurements, including forced vital capacity (FVC), forced expiratory volume in one second (FEV₁), and FEV₁/FVC were obtained, and z-scores were calculated using the GLI-2022 equations. Mean z-scores, age and height were assessed using linear regression and quantile analyses. Mean z-scores for all spirometric measurements were above zero in both sexes. Among females, mean z-scores for FEV₁, FVC and FEV₁/FVC were 1.18 (SD 1.41), 0.81 (SD 1.29) and 0.666 (SD 0.92) respectively. In males, the corresponding values were 0.96 (SD 1.41), 0.61 (SD 1.30) and 0.643 (SD 1.02), with p < 0.001 suggesting that the GLI-2022 equations systematically underestimated lung function. None of the mean z-scores fell within the physiologically acceptable range (±0.5), indicating a poor fit. Additionally, z-scores varied significantly with age and height. Taller and older individuals showed lower FEV₁ and FVC z-scores, indicating an overestimation of lung function. This variability was more pronounced in males. The GLI-2022 equations systematically underestimated FEV₁ and FVC of the Iraqi population, with mean z-scores exceeding the acceptable ±0.5 range. Age- and height-dependent deviations further indicate that GLI-2022 does not adequately represent this population, underscoring the need for regional validation before adopting these equations to ensure accurate diagnosis and appropriate clinical management.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。